For example, animal studies have shown that GLP-1 RA use is associated with natriuresis and diureses [35, 36] and that these agents also reduce risk factors of diabetic nephropathy, by reducing urine albumin levels [37] and inhibiting the development of hypertension [38]. This evidence concerns the gene ALB and diabetic kidney disease.